FindTrial
Sign In

Comparison of the incidence of postoperative acute kidney injury following the administration of remimazolam or sevoflurane in elderly patients undergoing total knee arthroplasty - Randomized controlled trial -

Comparison of the incidence of postoperative acute kidney injury following the administration of remimazolam or sevoflurane in elderly patients undergoing total knee arthroplasty - Randomized controlled trial -

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007782
Enrollment
78
Registered
2022-10-07
Start date
2022-09-19
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : To compare the incidence of postoperative acute renal injury between the two groups when remimazolam or sevoflurane was used to maintain anesthesia.

Sponsors

Kyung Hee University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Elderly patients over 65 years of age who are scheduled to undergo total knee arthroplasty under general anesthesia

Exclusion criteria

Exclusion criteria: (1) Age 64 or younger (2) Allergic to remimazolam or sevoflurane or use is contraindicated (3) Undergoing dialysis due to preoperative renal failure (4) Revision total knee arthroplasty (5) Second surgery if surgery is scheduled for both knees in a single administration (6) When both knees are operated at the same time (7) In case of American Society of Anesthesiologists classification IV or higher (8) In case of severe obesity with a body mass index of 35 kg/m^2 or more

Design outcomes

Primary

MeasureTime frame
post operative acute kidney injury—

Secondary

MeasureTime frame
post operative urinary retention—

Countries

Korea, Republic of

Contacts

Public ContactSangho Lee

Kyung Hee University Hospital

silzzang15@naver.com+82-2-958-8589

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026